ImmunologybioRxivPreprint
Rasal1 impairment unleashes anticancer immunity - a focus on T cells
Mark E. Issa, Alejandro Schcolnik‐Cabrera
This study shows that impairing Rasal1 enhances T cell antitumor immunity and improves responses to PD-1 therapy in melanoma.
DOI 10.64898/2026.01.19.700452